Literature DB >> 28820313

RIP off STAT3 to counteract tumor progression.

Jawahar Kopparam1, Etienne Meylan1.   

Abstract

Entities:  

Keywords:  RIP4; STAT3; lung adenocarcinoma; mouse models of cancer; oncogenic Kras; tumor dedifferentiation

Mesh：

Substances：

Year:  2017        PMID： 28820313      PMCID： PMC5628643          DOI： 10.1080/15384101.2017.1360643

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

1.  Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis.

Authors:  Chen-Hua Chuang; Peyton G Greenside; Zoë N Rogers; Jennifer J Brady; Dian Yang; Rosanna K Ma; Deborah R Caswell; Shin-Heng Chiou; Aidan F Winters; Barbara M Grüner; Gokul Ramaswami; Andrew L Spencley; Kimberly E Kopecky; Leanne C Sayles; E Alejandro Sweet-Cordero; Jin Billy Li; Anshul Kundaje; Monte M Winslow
Journal:  Nat Med       Date:  2017-02-13       Impact factor: 53.440

Review 2.  STAT3 the oncogene - still eluding therapy?

Authors:  Matthew S Wake; Christine J Watson
Journal:  FEBS J       Date:  2015-04-22       Impact factor: 5.542

3.  Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis.

Authors:  Selma Masri; Thales Papagiannakopoulos; Kenichiro Kinouchi; Yu Liu; Marlene Cervantes; Pierre Baldi; Tyler Jacks; Paolo Sassone-Corsi
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

4.  IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.

Authors:  Mauricio S Caetano; Huiyuan Zhang; Amber M Cumpian; Lei Gong; Nese Unver; Edwin J Ostrin; Soudabeh Daliri; Seon Hee Chang; Cesar E Ochoa; Samir Hanash; Carmen Behrens; Ignacio I Wistuba; Cinthya Sternberg; Humam Kadara; Carlos Gil Ferreira; Stephanie S Watowich; Seyed Javad Moghaddam
Journal:  Cancer Res       Date:  2016-04-01       Impact factor: 12.701

5.  Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling.

Authors:  Hua Gao; Goutam Chakraborty; Zhanguo Zhang; Intissar Akalay; Mayur Gadiya; Yaquan Gao; Surajit Sinha; Jian Hu; Cizhong Jiang; Muzaffar Akram; Edi Brogi; Birgit Leitinger; Filippo G Giancotti
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

6.  RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation.

Authors:  Jawahar Kopparam; Johanna Chiffelle; Paolo Angelino; Alessandra Piersigilli; Nadine Zangger; Mauro Delorenzi; Etienne Meylan
Journal:  Cell Death Differ       Date:  2017-06-02       Impact factor: 15.828
  6 in total
  1 in total

1.  Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.

Authors:  Nirmala Chandralega Kampan; Mutsa Tatenda Madondo; Orla M McNally; Andrew N Stephens; Michael A Quinn; Magdalena Plebanski
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.